Research and Development Tax Credits: What Smart Business Owners Know for 2025
Research and development tax credits have seen major changes with the Opportunity for Businesses and Benefits Act (OBBBA) signed into law on July 4, 2025. This landmark legislation brought back permanent immediate expensing of domestic R&E expenditures. The law reversed the previous requirement that made businesses amortize these costs over five years.
The changes to R&D tax credit rules offer potentially beneficial opportunities for businesses. Companies can now fully deduct domestic R&E costs in the year they incur them, instead of spreading them across extended periods. On top of that, businesses can fully deduct any unamortized R&E costs from 2022–2024 in tax year 2025. They also have the option to spread these costs evenly between the 2025 and 2026 tax years. Small business taxpayers who have average annual gross receipts of $31 million or less over the previous three tax years get extra flexibility. They can amend their returns for 2022-2024 to apply these new rules.
In this piece, we’ll explore what business owners should know about the revolutionized research and development tax credit world. We’ll provide clear explanations about immediate expensing rules, retroactive options, and compliance deadlines to help you discover the full potential of these valuable tax benefits.
What changed in 2025 for Research and Development Tax Credits
Image Source: OpStart
The OBBBA changed how businesses handle their R&D tax credits in 2025. Companies can now manage their R&D spending with more flexibility after years of required capitalization.
Immediate expensing for domestic R&D is back
The return of immediate expensing for domestic research and experimental (R&E) expenditures stands out as the biggest change. Companies can now deduct qualified domestic R&E expenditures in the same year they spend the money, starting after December 31, 2024. This new approach reverses the Tax Cuts and Jobs Act (TCJA) rules that made businesses spread these costs over five years since 2022. Tech companies will benefit because software development costs still count as R&E expenditures that qualify for immediate expensing.
Foreign R&D still requires 15-year amortization
The new rules are stricter for foreign research activities. Companies must spread their foreign R&E costs over 15 years, just like under the TCJA rules. This split system clearly favors research done in the U.S. Companies doing R&D work internationally need to track their domestic and foreign research separately to get the best tax benefits.
New Section 174A and optional capitalization
Section 174A, which the OBBBA added to the Internal Revenue Code, brings back the pre-TCJA rules for domestic research spending. Companies don’t have to deduct R&E costs right away – they have options for handling these expenses. Under Section 174A, businesses can:
- Deduct domestic R&E expenditures in the year incurred, or
- Choose to capitalize and spread these costs over at least 60 months
On top of that, Section 174A(c) lets companies start their amortization when they first see benefits from their research. This differs from TCJA’s mid-year start date. Companies must make this choice by their tax return deadline, including extensions. The choice applies to that tax year and future years unless they get permission to change methods.
Retroactive options for 2022–2024 R&D expenses
The OBBBA gives business owners a great way to get retroactive options to handle R&D expenses from 2022-2024. These options can tap into the full potential of tax savings that weren’t available before.
Option 1: Amend past returns to deduct full expenses
Small businesses can choose to apply Section 174A retroactively by filing amended returns for tax years beginning after December 31, 2021, and before January 1, 2025. This approach lets you deduct domestic R&D expenses right away in the year they occurred. The capitalization requirement gets reversed. You’ll get tax benefits faster this way, but you must amend returns for all applicable years – you can’t pick and choose individual years. The process needs careful handling, especially when you have claimed the research credit. You’ll need to look at Section 280C coordination because it might lower the value of credits you claimed before.
Option 2: Deduct remaining amounts in 2025 or split over 2025–2026
Another choice lets businesses speed up their remaining unamortized domestic R&D costs from 2022-2024. You can deduct them fully in 2025 or split them equally between 2025 and 2026. This option works for all taxpayers whatever their size and doesn’t need amended returns. This works best if you expect higher income in 2025-2026 that could use bigger deductions.
Eligibility criteria for small businesses
Your business needs to meet two main requirements to qualify for retroactive application. The first requirement follows the Section 448(c) gross receipts test – your average annual gross receipts should be $31 million or less for the three years before 2025. The second rule states your business can’t be a tax shelter in 2025. The gross receipts test looks at all affiliated entities, so you need to calculate carefully.
Key deadlines to file amended or superseding returns
You have until July 6, 2026, to make retroactive elections, or until the statute of limitations expires for the 2022 tax year – whichever comes first. Many businesses need to act quickly since 2022 calendar-year returns might expire as early as March 15, 2026. A superseding return can be submitted within six months of the original due date if you’ve already filed your 2024 return.
How R&D tax credits interact with deductions
Image Source: VJM Global
Businesses must deal with complex rules between research tax credits and deductions due to immediate expensing for domestic R&D costs. The OBBBA brought back key coordination rules that show how these benefits work together.
Understanding Section 280C limitations
Starting with tax years after December 31, 2024, businesses claiming the full research credit need to reduce their Section 174A deductions by the credit amount claimed. This rule prevents getting double tax benefits from the same expenses. Small businesses choosing to apply Section 174A by amending past returns must also apply these Section 280C coordination rules to those returns.
Avoiding double benefits with IRC §41 credit
Double tax benefits for research expenses are not allowed by the IRS. Businesses can either claim the full R&D credit and lower their R&D expense deductions by that amount, or take a smaller credit without changing the deduction. This approach prevents taxpayers from getting both the full credit and deduction at once, which would double the tax benefit.
When the credit may reduce the value of deductions
Businesses that capitalize research costs must reduce the capitalized amount if their research credit exceeds the deduction for qualified research expenses. Tax rates play a big role here. Corporate tax rates are 21% while individual rates can go up to 37%. Pass-through entities might find the Section 280C election more valuable because of this difference.
Choosing between deduction timing and credit value
The reduced credit equals the gross credit minus what you get when multiplying the gross credit by the maximum tax rate of 21%. This election needs to be made on the original return filed on time, including extensions. Once made, you cannot change the election for that tax year. Companies should check how their tax bill changes based on making or skipping the Section 280C election.
IRS guidance and compliance steps for 2025
The IRS released crucial guidance through Revenue Procedure 2025-28 in August 2025. This guidance gives businesses a clear path to navigate the research and development tax credit landscape under the OBBBA.
Rev. Proc. 2025-28: what it clarifies
Revenue Procedure 2025-28 details the process to make elections under the new Section 174A. Businesses can now choose to deduct domestic R&D costs right away or spread them over 60 months or more. Small businesses get specific instructions about retroactive applications for tax years after December 31, 2021. The procedure handles both domestic and foreign R&D expenditures differently.
Using Form 3115 for accounting method changes
Rev. Proc. 2025-28 simplifies the usual Form 3115 requirement for accounting method changes. Businesses need only attach a brief statement to their tax return during the 2025 transition year instead of filling out the complete form. This simplified process works only for changes made in the first taxable year starting after December 31, 2024. Traditional Form 3115 filing requirements come back into play for later years, with modified §481(a) adjustments.
Deemed elections and automatic consent rules
Businesses that file timely returns by November 15, 2025, get automatic consent when they properly deduct R&D expenses. Qualifying small businesses benefit from “deemed elections” that automatically apply OBBBA treatment. These automatic provisions must stay consistent across all applicable years. Companies that filed their 2024 returns have until November 15, 2025, to submit superseding returns.
State tax conformity and AMT considerations
State conformity varies substantially from federal changes. California updated its IRC conformity date to January 1, 2025, through Senate Bill 711 and allows full expensing of both U.S. and foreign R&E costs. AMT calculations require individuals to amortize R&E expenditures over 10 years. This creates potential differences for partners who receive K-1s from flow-through entities. Companies with average annual gross receipts under $50 million can use R&D credits to offset both regular tax and AMT.
Conclusion
The R&D tax credits changes in 2025 are a big win for businesses that invest in domestic innovation. This piece shows how OBBBA has altered the research and development tax map. The new rules let companies expense their domestic R&E costs right away. Companies doing research outside the U.S. still need to spread these costs over 15 years.
Business owners have key choices to make about these new rules. You can pick immediate expensing under Section 174A or spread the costs over at least 60 months. On top of that, small businesses with gross receipts under $31 million can save money through retroactive options for 2022-2024 R&D expenses.
Your planning needs to account for timing. The July 6, 2026 deadline is crucial, especially if you want to amend your 2022 tax returns. Working with qualified tax professionals early will help you get the most from these benefits.
R&D tax credits and deductions need careful handling. Section 280C rules stop you from getting double tax benefits. You must choose between the full research credit with lower deductions or a reduced credit without changing deductions. Pass-through entities should pay extra attention because corporate and individual tax rates differ.
There’s another reason to think carefully – state tax rules. States like California have their own way of handling R&E costs, despite federal changes. So your R&D tax strategy needs to work at both state and federal levels.
The refreshed R&D tax credit system helps American businesses that invest in breakthroughs. Smart owners will act fast to understand these changes and save on taxes while following the rules. The system might be complex, but proper planning can boost your bottom line by a lot and propel future research.
Key Takeaways
Smart business owners can now leverage significant tax advantages from the 2025 R&D credit changes, but timing and strategic decisions are crucial for maximizing benefits.
• Domestic R&D gets immediate expensing again: The OBBBA permanently restored full deduction of domestic R&E costs in the year incurred, reversing the 5-year amortization requirement.
• Small businesses can reclaim past savings: Companies with under $31M average gross receipts can amend 2022-2024 returns to apply new rules retroactively by July 6, 2026.
• Choose your deduction strategy wisely: Businesses can either take immediate expensing or elect 60+ month capitalization, but must coordinate with Section 280C to avoid double benefits.
• Foreign R&D still faces restrictions: While domestic research gets favorable treatment, foreign R&E expenditures must still be amortized over 15 years under the new bifurcated system.
• Act before critical deadlines expire: The window to amend 2022 returns may close as early as March 15, 2026, making immediate consultation with tax professionals essential.
The key is understanding that these changes create both opportunities and compliance requirements. Businesses that act strategically can unlock substantial tax savings while those who delay may miss valuable retroactive benefits entirely.
FAQs
Q1. What are the key changes to R&D tax credits for 2025? The main change is the return of immediate expensing for domestic R&D costs. Businesses can now fully deduct qualified domestic R&E expenditures in the year they’re incurred, reversing the previous requirement to amortize these costs over five years. However, foreign R&D expenses still require 15-year amortization.
Q2. How can small businesses benefit from the new R&D tax credit rules? Small businesses with average annual gross receipts of $31 million or less can retroactively apply the new rules to tax years 2022-2024. They have the option to amend past returns to deduct full R&D expenses or accelerate remaining unamortized costs in 2025 or split them between 2025 and 2026.
Q3. What is the deadline for making retroactive R&D tax credit elections? The deadline to make retroactive elections is July 6, 2026, or the expiration of the statute of limitations for the 2022 tax year, whichever comes first. For many businesses, especially those with calendar-year returns, this could be as early as March 15, 2026.
Q4. How do R&D tax credits interact with deductions? Businesses claiming the full research credit must reduce their Section 174A deductions by the amount of the credit claimed to avoid double tax benefits. Alternatively, they can choose to take a reduced credit without adjusting the deduction. The choice depends on factors like tax rates and overall tax liability.
Q5. What compliance steps should businesses take for the 2025 R&D tax changes? Businesses should review IRS guidance, particularly Revenue Procedure 2025-28, which provides instructions for making elections under the new Section 174A. For the 2025 transition year, a brief statement can be attached to the tax return instead of filing Form 3115 for accounting method changes. It’s also crucial to consider state tax conformity and AMT implications.
